Literature DB >> 17360749

Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.

Ashley Steed1, Thorsten Buch, Ari Waisman, Herbert W Virgin.   

Abstract

Gammaherpesviruses are important pathogens whose lifelong survival in the host depends critically on their capacity to establish and reactivate from latency, processes regulated by both viral genes and the host immune response. Previous work has demonstrated that gamma interferon (IFN-gamma) is a key regulator of chronic infection with murine gammaherpesvirus 68 (gammaHV68), a virus that establishes latent infection in B lymphocytes, macrophages, and dendritic cells. In mice deficient in IFN-gamma or the IFN-gamma receptor, gammaHV68 gene expression is altered during chronic infection, and peritoneal cells explanted from these mice reactivate more efficiently ex vivo than cells derived from wild-type mice. Furthermore, treatment with IFN-gamma inhibits reactivation of gammaHV68 from latently infected wild-type peritoneal cells, and depletion of IFN-gamma from wild-type mice increases the efficiency of reactivation of explanted peritoneal cells. These profound effects of IFN-gamma on chronic gammaHV68 latency and reactivation raise the question of which cells respond to IFN-gamma to control chronic gammaHV68 infection. Here, we show that IFN-gamma inhibited reactivation of peritoneal cells and spleen cells harvested from mice lacking B lymphocytes, but not wild-type spleen cells, suggesting that IFN-gamma may inhibit reactivation in a cell type-specific manner. To directly test this hypothesis, we expressed the diphtheria toxin receptor specifically on either B lymphocytes or macrophages and used diphtheria toxin treatment to deplete these specific cells in vivo and in vitro after establishing latency. We demonstrate that macrophages, but not B cells, are responsive to IFN-gamma-mediated suppression of gammaHV68 reactivation. These data indicate that the regulation of gammaherpesvirus latency by IFN-gamma is cell type specific and raise the possibility that cell type-specific immune deficiency may alter latency in distinct and important ways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360749      PMCID: PMC1900319          DOI: 10.1128/JVI.00108-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

2.  Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages.

Authors:  N Faust; F Varas; L M Kelly; S Heck; T Graf
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

3.  Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage.

Authors:  A J Dal Canto; H W Virgin; S H Speck
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice.

Authors:  R Rochford; M L Lutzke; R S Alfinito; A Clavo; R D Cardin
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice.

Authors:  Emilio Flaño; In-Jeong Kim; John Moore; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Authors:  Scott A Tibbetts; Linda F van Dyk; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency.

Authors:  Eric T Clambey; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.

Authors:  Kelly B McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

9.  Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages.

Authors:  R M Presti; D L Popkin; M Connick; S Paetzold; H W Virgin
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells.

Authors:  Emilio Flaño; In-Jeong Kim; David L Woodland; Marcia A Blackman
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

View more
  40 in total

1.  Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Authors:  Ching-Yi Tsai; Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

2.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

3.  Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-γ- or IL-17-producing γδ T cells upon infection.

Authors:  Miguel Chaves-Ferreira; Francisco d'Orey; Julie C Ribot; Mélanie Wencker; Natacha Gonçalves-Sousa; Jérémie Decalf; João P Simas; Adrian C Hayday; Bruno Silva-Santos
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

4.  gamma-Herpesvirus-induced protection against bacterial infection is transient.

Authors:  Eric J Yager; Frank M Szaba; Larry W Kummer; Kathleen G Lanzer; Claire E Burkum; Stephen T Smiley; Marcia A Blackman
Journal:  Viral Immunol       Date:  2009-02       Impact factor: 2.257

5.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

6.  ATM supports gammaherpesvirus replication by attenuating type I interferon pathway.

Authors:  Eric J Darrah; Kyle P Stoltz; Mitchell Ledwith; Vera L Tarakanova
Journal:  Virology       Date:  2017-07-18       Impact factor: 3.616

7.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

8.  Type I Interferon Signaling to Dendritic Cells Limits Murid Herpesvirus 4 Spread from the Olfactory Epithelium.

Authors:  Clara Lawler; Philip G Stevenson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter.

Authors:  T A Reese; B S Wakeman; H S Choi; M M Hufford; S C Huang; X Zhang; M D Buck; A Jezewski; A Kambal; C Y Liu; G Goel; P J Murray; R J Xavier; M H Kaplan; R Renne; S H Speck; M N Artyomov; E J Pearce; H W Virgin
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

10.  Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes.

Authors:  Katherine S Lee; Carlyne D Cool; Linda F van Dyk
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.